We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+0.51%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$11.2B
AUM Growth
-$244M
Cap. Flow
-$183M
Cap. Flow %
-1.64%
Top 10 Hldgs %
22.89%
Holding
2,613
New
177
Increased
266
Reduced
1,243
Closed
46

Sector Composition

Rank Sector Weight
1 Technology 21.19%
2 Financials 13.17%
3 Healthcare 12.67%
4 Consumer Discretionary 11.48%
5 Industrials 8.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SKYT
2451
DELISTED
SkyWater Technology
SKYT
$97.4K ﹤0.01%
+3,580
New +$93.2K
SYRS
2452
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$97K ﹤0.01%
+2,170
New +$106K
TACO
2453
DELISTED
Del Taco Restaurants, Inc. Common Stock
TACO
$96.8K ﹤0.01%
+11,093
New +$98.2K
CBAY
2454
DELISTED
Cymabay Therapeutics
CBAY
$96.7K ﹤0.01%
+26,489
New +$104K
ALTG icon
2455
Alta Equipment Group
ALTG
$254M
$96.7K ﹤0.01%
+7,040
New +$92.3K
RJET
2456
Republic Airways Holdings
RJET
$962M
$95.9K ﹤0.01%
+834
New +$104K
ELTX icon
2457
Elicio Therapeutics
ELTX
$80.4M
$95.8K ﹤0.01%
+981
New +$106K
TG icon
2458
Tredegar Corp
TG
$281M
$95.4K ﹤0.01%
7,835
VLDR
2459
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
$95.3K ﹤0.01%
16,095
-12,653
-44% -$95.1K
GPX
2460
DELISTED
GP Strategies Corp.
GPX
$95.1K ﹤0.01%
+4,596
New +$91.2K
SPFI icon
2461
South Plains Financial
SPFI
$858M
$94.8K ﹤0.01%
+3,888
New +$90.4K
BCOV
2462
DELISTED
Brightcove, Inc.
BCOV
$94.4K ﹤0.01%
8,178
-7,165
-47% -$86.6K
VKTX icon
2463
Viking Therapeutics
VKTX
$3.97B
$94.3K ﹤0.01%
15,023
-12,499
-45% -$77.2K
NRIM icon
2464
Northrim BanCorp
NRIM
$599M
$94.3K ﹤0.01%
+8,876
New +$91.6K
JNCE
2465
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$94K ﹤0.01%
+12,647
New +$78.3K
CMRX
2466
DELISTED
Chimerix, Inc.
CMRX
$93.9K ﹤0.01%
15,165
-13,374
-47% -$91.9K
ORRF icon
2467
Orrstown Financial Services
ORRF
$850M
$93.2K ﹤0.01%
+3,982
New +$92.4K
BHR
2468
Braemar Hotels & Resorts
BHR
$139M
$93K ﹤0.01%
+19,183
New +$100K
XXII
2469
22nd Century Group
XXII
$1.49M
0
CLVS
2470
DELISTED
Clovis Oncology, Inc.
CLVS
$92.6K ﹤0.01%
20,765
-17,813
-46% -$85.8K
CUE icon
2471
Cue Biopharma
CUE
$128M
$92.5K ﹤0.01%
212
-218
-51% -$76K
LFCR icon
2472
Lifecore Biomedical
LFCR
$181M
$92.1K ﹤0.01%
+9,994
New +$109K
RLGT icon
2473
Radiant Logistics
RLGT
$400M
$91.6K ﹤0.01%
+14,341
New +$92.3K
SOLY
2474
DELISTED
Soliton, Inc.
SOLY
$91.5K ﹤0.01%
+4,494
New +$96.1K
INFU icon
2475
InfuSystem Holdings
INFU
$244M
$91K ﹤0.01%
+6,986
New +$114K

Similar funds

MetLife Investment Management's Q3 2021 Portfolio in Review

As of Q3 2021, MetLife Investment Management held 2,613 positions worth $11.2B, down 2.1% from $11.4B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

MetLife Investment Management's Q3 2021 filing shows 177 new, 266 increased, 1,243 reduced and 46 closed positions. Its largest new stake was Moderna: 79,316 shares worth $30.5M. The largest sale was Energy Transfer Partners, an estimated $35.7M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q3 2021 buy was Moderna: 79,316 shares worth $30.5M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $39.7M increase.
  • MetLife Investment Management's biggest Q3 2021 reduction was Energy Transfer Partners, cutting an estimated $35.7M.
  • MetLife Investment Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $9.28M.
  • MetLife Investment Management's ten largest holdings make up 23% of its $11.2B portfolio in Q3 2021.
  • MetLife Investment Management opened 177 new positions and closed 46 in Q3 2021.
  • MetLife Investment Management's portfolio value fell 2.1% quarter-over-quarter to $11.2B.

Based on MetLife Investment Management's 13F filing for Q3 2021, filed 15 Nov 2021.